Table 3.
Comparison and univariate analysis of comorbidities with death among COVID19 patients (N = 4530).
| CO MORBIDITIES | DEATH (N = 381) | SURVIVORS (N = 4149) | TOTAL N (%) |
P VALUE BY CHI – SQUARE TEST | PREVALENCE RATIO (95% CI) | P VALUE |
|---|---|---|---|---|---|---|
| CKD | 64 (61.5%) | 40 | 104 | <0.001b | 8.592 (6.568–11.239) | <0.001b |
| Malignancy | 15 (50%) | 15 | 30 | <0.001b | 6.148 (3.668–10.302) | <0.001b |
| No DM/HT/CHDa | 117 (3.9%) | 2907 | 3024 | <0.001b | ||
| Only DM | 86 (13.5%) | 552 | 638 | 3.484 (2.637–4.602) | <0.001b | |
| Only HT | 32 (11.1%) | 257 | 289 | 2.862 (1.936–4.231) | <0.001b | |
| only CHD | 6 (11.3%) | 47 | 53 | 2.926 (1.288–6.646) | 0.010b | |
| DMwithHT | 99 (25.1%) | 295 | 394 | 6.494 (4.969–8.487) | <0.001b | |
| DMwith CHD | 14 (28.6%) | 35 | 49 | 7.385 (4.242–12.854) | <0.001b | |
| HTwith CHD | 7 (25.9%) | 20 | 27 | 6.701 (3.126–14.366) | <0.001b | |
| DM, HTand CHD | 20 (35.7%) | 36 | 56 | 9.231 (5.745–14.832) | <0.001b | |
| Lung disease | 22 (18.6%) | 96 | 118 | <0.001b | 2.291 (1.490–3.524) | <0.001b |
| Other chronic disease | 61 (27.4%) | 162 | 223 | <0.001b | 3.682 (2.800–4.841) | <0.001b |
CKD-Chronic renal disease, DM-Diabetesmellitus, HT-Hypertension, CHD -Heart disease.
a
– reference in binary logistic regression to find out univariate unadjusted prevalence ratio.
b
P-value <0.05,statistically significant.